
News|Articles|October 26, 2026
Research, Regulation, and Longevity Trends: What’s Next for Pet Supplements
Author(s)Erin McEvoy
From canine arthritis to the microbiome, and from the proposed Animal Health Supplement Act to owners’ views on longevity, here is what has been developing for companion animal products.
Advertisement
Advertisement
As dogs, cats, and other pets are increasingly treated like members of the family, opportunities for meeting the health needs of companion animals are growing. More research is being conducted on supplements for various conditions, more attention is being given to regulatory concerns in the category, and companies are examining the expectations pet owners have around supplements. Here’s a look into what’s new and what may be next.
Related to this article

The palm phytonutrient supplier will show STGaia, TocoGaia, and PetGaia at the event and preview a planned research grant program.

The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.

Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.

Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.

The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.

AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.

Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Advertisement
Advertisement

